Расширенный поиск

Клиническое значение и оценка содержания кислорода в органах дыхания

Полный текст:

Об авторе

Д. Келер
Специализированная больница Kloster Grafschaft
г. Шмалленберг

Список литературы

1. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: а clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann. Intern. Med. 1980; 93: 391–398.

2. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981; 1: 681–686.

3. Roussos C., Koutsoukou A. Respiratory failure. Eur. Respir. 2003; 47: 3–14.

4. Begin P., Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1991; 143: 905–912.

5. Köhler D., Schönhofer B., Haidl P., Kemper P. Ursache und "Therapie" der Hyperkapnie. Pneumologie 2000; 54: 434–439.

6. Köhler D., Schönhofer B. How important is the differentiation between apnea and hypopnea? Respiration 1997; 64 (suppl. 1): 15–21.

7. Nappi J. Anemia in patients with coronary artery disease. Am. J. Health Syst. Pharm. 2003; 60: 4–8.

8. Palevsky H.I., Fishman A.P. Chronic cor pulmonale. Etiology and management. J. A. M. A. 1990; 263: 2347–2353.

9. Schönhofer B., Sonneborn M., Haidl P. et al. Comparison of two different modes for non-invasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device. Eur. Respir. J. 1997; 10: 184–191.

10. Schönhofer B.,Wallstein S., Wiese C., Köhler D. Noninvasive mechanical ventilation improves endurance performance in patients with chronic respiratory failure due to thoracic restriction. Chest 2001; 119: 1371–1378.

11. Murray J.F., Nadel J.A., Murray R. Textbook of respiratory medicine. Philadelphia, London: WB Saunders; 2000.

12. Timms R.M., Tisi G.M. The effect of short-term oxygen supplementation on oxygen hemoglobin affinity in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1985; 131: 69–72.

13. Howald H., Pette D., Simoneau J.A. et al. Effect of chronic hypoxia on muscle enzyme activities. Int. J. Sports Med. 1990; 11: 10–14.

14. Simon L.M., Robin E.D., Phillips J.R. et al. Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2 . J. Clin. Invest. 1977; 59: 443–448.

15. Terrados N., Jansson E., Sylven C., Kaijser L. Is hypoxia a stimulus for synthesis of oxidative enzymes and myoglobin? J. Appl. Physiol. 1990; 68: 2369–2372.

16. Schonhofer B., Barchfeld T.,Wenzel M., Kohler D. Longterm effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure. Thorax 2001; 56: 524–528.

17. Hayes M.A., Timmins A.C., Yau E.H. et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 1994; 330: 1717–1722.

18. Hayes M.A.,Timmins A.C.,Yau E.H. et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit. Care Med. 1997; 25: 926–936.

19. Lorente J.A., Landin L., De Pablo R. et al. Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit. Care Med. 1993; 21: 1312–1318.

20. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with newonset heart failure. Circulation 2003; 107: 223–225.

21. Felker G.M., Gattis W.A., Leimberger J.D. et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am. J. Cardiol. 2003; 92: 625–628.

22. Hebert P.C., Wells G., Blajchman M.A. et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N. Engl. J. Med. 1999; 11; 340: 409–417.

23. Hebert P.C., Yetisir E., Martin C. et al. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit. Care Med. 2001; 29: 227–234.

24. Khanna M.P., Hebert P.C., Fergusson D.A. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus. Med. Rev. 2003; 17: 110–119.

25. Litmathe J., Boeken U., Feindt P., Gams E. Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac. Cardiovasc. Surg. 2003; 51: 17–21.

26. Kosiborod M., Smith G.L., Radford M.J. et al. The prognostic importance of anemia in patients with heart failure. Am. J. Med. 2003; 114:112–119.

27. Silverberg D.S., Wexler D., Sheps D. et al. The effect of correction of mildanemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J. Am. Coll. Cardiol. 2001; 37: 1775–1780.

28. Hebert P.C.,Wells G., Marshall J. et al. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group. J. A. M. A. 1995; 273: 1439–1444.

29. Schöonhofer B., Wenzel M., Geibel M., Köohler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit. Care Med. 1998; 26: 1824–1828.

30. Schöonhofer B., Bohrer H., Köohler D. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998; 53: 181–184.

31. Gattinoni L., Brazzi L., Pelosi P. et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N. Engl. J. Med. 1995; 333: 1025–1032.

32. Heyland D.K., Cook D.J., King D. et al. Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit. Care Med. 1996; 24: 517–524.

33. Notterman D.A. Inotropic agents. Catecholamines, digoxin, amrinone. Crit. Care Clin. 1991; 7: 583–613.

34. Connett R.J., Honig C.R., Gayeski T.E., Brooks G.A. Defining hypoxia: a systems view of VO2 , glycolysis, energetics, and intracellular PO2 . J. Appl. Physiol. 1990; 68: 833–842.

35. Ferguson G.T., Irvin C.G., Cherniack R.M. Relationship of diaphragm glycogen, lactate, and function to respiratory failure. Am. Rev. Respir. Dis. 1990; 141: 926–932.

36. Lockhat D., Roussos C., Ianuzzo C.D. Metabolite changes in the loaded hypoperfused and failing diaphragm. J. Appl. Physiol. 1988; 65: 1563–1571.

37. Wasserman K. The anaerobic threshold measurement to evaluate exercise performance. Am. Rev. Respir. Dis. 1984; 129: 35–40.

38. Gilbert E.M., Haupt M.T., Mandanas R.Y. et al. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am. Rev. Respir. Dis. 1986; 134: 873–878.

39. Hussain S.N., Roussos C. Distribution of respiratory muscle and organ blood flow during endotoxic shock in dogs. J. Appl. Physiol. 1985; 59: 1802–1808.

40. Viires N., Sillye G., Aubier M. et al. Regional blood flow distribution in dog during induced hypotension and low cardiac output. Spontaneous breathing versus artificial ventilation. J. Clin. Invest. 1983; 72: 935–947.

41. Greif R., Akca O., Horn E.P. et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N. Engl. J. Med. 2000; 342: 161–167.

42. Lobo S.M., Salgado P.F., Castillo V.G. et al. Effects of maximizing oxygen delivery on morbidity and mortality in highrisk surgical patients. Crit. Care Med. 2000; 28: 3396–3404.

43. Jensen L.A., Onyskiw J.E., Prasad N.G. Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart Lung 1998; 27: 387–408.

44. Kelleher J.F. Pulse oximetry. J. Clin. Monit. 1989; 5: 37–62.

45. Bernstein D., Teitel D.F. Myocardial and systemic oxygenation during severe hypoxemia in ventilated lambs. Am. J. Physiol. 1990; 258: 1856–1864.

46. Borgia J.F., Horvath S.M. Effects of acute prolonged hypoxia on cardiovascular dynamics in dogs. J. Appl. Physiol. 1977; 43: 784–789.

47. Grubbstrom J., Berglund B., Kaijser L. Myocardial oxygen supply and lactate metabolism during marked arterial hypoxaemia. Acta Physiol. Scand. 1993; 149: 303–310.

48. Kaijser L., Grubbstrom J., Berglund B. Myocardial lactate release during prolonged exercise under hypoxaemia. Acta Physiol. Scand. 1993; 149: 427–433.

49. Mazer C.D., Stanley W.C., Hickey R.F. et al. Myocardial metabolism during hypoxia: maintained lactate oxidation during increased glycolysis. Metabolism 1990; 39: 913–918.

50. Roach R.C., Koskolou M.D., Calbet J.A., Saltin B. Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am. J. Physiol. 1999; 276: 438–445.

51. Taylor P.M. Effects of hypoxia on endocrine and metabolic responses to anaesthesia in ponies. Res. Vet. Sci. 1999; 66: 39–44.

52. Todd M.M., Wu B., Maktabi M. et al. Cerebral blood flow and oxygen delivery during hypoxemia and hemodilution: role of arterial oxygen content. Am. J. Physiol. 1994; 267: H2025–H2031.

53. Faraci F.M., Kilgore D.L. Jr., Fedde M.R. Oxygen delivery to the heart and brain during hypoxia: Peking duck vs. barheaded goose. Am. J. Physiol. 1984; 247: R69–R75.

54. Hayes M.A., Yau E.H., Timmins A.C., Hinds C.J.,Watson D.: Response of critically ill patients to treatment aimed at achieving supranormal oxygen delivery and consumption. Relationship to outcome. Chest 1993; 103: 886–895.

55. Wu W.C., Rathore S.S., Wang Y. et al. Blood transfusion in elderly patients with acute myocardial infarction. N. Engl. J. Med. 2001; 345: 1230–1236.


Для цитирования:

Келер Д. Клиническое значение и оценка содержания кислорода в органах дыхания. Пульмонология. 2008;(3):102-106.

For citation:

Kohler D. Clinical relevance of oxygen supply. PULMONOLOGIYA. 2008;(3):102-106. (In Russ.)

Просмотров: 115

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)